MSB 8.43% $1.35 mesoblast limited

Ann: Response to ASX Price Query , page-93

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 30,372 Posts.
    lightbulb Created with Sketch. 1858
    moreforme:

    I've helpfully pointed out the biotech forum to madamswr on previous occasions.

    In fact, I suggested they might have a use for his study about how shorting helps you select ASX biotechs.

    (except of course, there are very few biotechs on the ASX that can be shorted...).

    point never acknowledged...of course.

    BTW I hold quite a few small cap biotechs, and if you can get a good biotech in the early stages, all power to the LT holders. It's a window that won't be open forever
    But yer, I've done my research and am convinced that MSB is undervalued.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.